Jun 4 |
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
May 30 |
Astria Therapeutics to Present at Upcoming Jefferies Healthcare Conference
|
May 24 |
Astria Therapeutics to Present at Upcoming Eastern Allergy Conference
|
May 23 |
Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Congress
|
May 11 |
We're Not Very Worried About Astria Therapeutics' (NASDAQ:ATXS) Cash Burn Rate
|
May 10 |
Astria TherapeuticS GAAP EPS of -$0.38 misses by $0.02
|
May 9 |
Astria Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update
|
May 8 |
Astria Therapeutics to Present at Upcoming Society for Investigative Dermatology Annual Meeting
|
Apr 9 |
Astria Therapeutics Appoints Sunil Agarwal to Its Board of Directors
|
Apr 3 |
Chief Medical Officer Christopher Morabito Sells 10,000 Shares of Astria Therapeutics Inc (ATXS)
|